TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA

por AHMED, MUBASHIR AYAZ, HOSSAIN ESHAN, SHAYET, HUSSEIN, SAMI, SUN, CHENYU, SANKARAN RAJAGOPALAN, KAMALNATH, HUSSEIN, KHALID
Publicado 2022